Freeline Therapeutics Rings the Nasdaq Stock Market Opening Bell in Celebration of its IPO

Published

Theresa Heggie, CEO, rang the Opening Bell in a virtual bell ringing ceremony. Freeline Therapeutics (Nasdaq: FRLN), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now